BioPharma Dive | Audience Snapshot 2022

Targeting biopharma leaders? Gain approval with this audience by reflecting the content preferences of over 125,500 BioPharma Dive subscribers in your strategy. 

BioPharma Dive is one of our parent company’s many industry-focused news publications, and it’s specifically designed for pharmaceutical and biotech leaders overseeing the business of drug development. We’ve collected the latest readership data and turned it into insights to help marketers better reach this niche. 

Marketers to biopharma leaders can expect to refine their content strategy with: 

• analysis of top-performing content (characteristics, formats, and approach recommendations)
• top industry issues and prevailing themes 
• top 10 best-performing articles
• top 5 most popular topics
• keywords that resonate

Targeting other industries? Explore all 22 of our audience snapshots.